Science

1.3 billion-forint developmental fund for three new projects at Semmelweis University

Three research groups of Semmelweis University have recently won a 1.3 billion-forint developmental fund within the framework of the Competitive Central Hungary Operational Programme (CCHOP). The winning projects, which are launched on 1st July, are lead by Dr. Erzsébet Ligeti, …

New research group of the Hungarian Brain Research Program (NAP) to improve the diagnostics and therapy of brain metastases

The primary objective of the Brain Metastasis Research Group lead by Dr. Zoltán Szállási, guest professor at the 2nd Department of Pathology is the better understanding of the genetic background of brain metastases, their genomic analysis and the establishment of …

Paper by Semmelweis researchers published in Nature on the progression of breast cancer metastasis

A scientific paper written in an international collaboration with the involvement of Semmelweis University’s researchers and published in the scientific journal Nature Communications describes the phylogenesis of breast tumours types and their metastases, which may help establish the correct treatment …

New opportunities for the diagnosis of diseases of the peripheral nervous system

Research that can immediately be implemented in patient care is being carried out by a research group of two people at the Department of Neurology within the framework of the Hungarian Brain Research Programme. Dr. Zsuzsanna Arányi, associate professor and …

151 presentations and posters at the PhD Scientific Days

151 PhD students from seven Doctoral Schools introduced their latest research and clinical results in eight presentation- and seven poster sections at one of Semmelweis University’s scientific programmes in the spring, the PhD Scientific Days. The conference has been organised …

New drug research in targeted tumour therapy

The research team of Eötvös Loránd University (ELTE), Semmelweis University’s Department of Genetics, Cell and Immunobiology and ComInnex R&D Inc. have started the development of compounds consisting of changeable components based on the type of tumor in order to achieve …

Dr. László Hangody: “The keys to success: a good team and love of the trade”

Dr. László Hangody, director of Semmelweis University’s Department of Traumatology and chief physician of the Department of Orthopaedics and Traumatology at the Uzsoki Hospital has recently received the Széchenyi award for his invention associated with mosaicplasty, which has been the …

M-Resist: IT-based assistance for resistant schizophrenia

The fifth plenary session of the members of the m-Resist programme was held at Semmelweis University. M-Resist is a multi-component programme based on information technology applications for treatment-resistant schizophrenia. The international project’s duration is 3 years and Hungary is represented …

26 lung transplantations in the cooperation of Semmelweis University and the National Institute of Oncology

The 25th and the 26th Hungarian lung transplantations were carried out almost at the same time. Both patients are recovering in stable conditions at the intensive care unit. The cooperation of the National Institute of Oncology (NIO) and Semmelweis University …

Dr. Éva Pállinger: a success story in artificial fertilisation

The collaborative research group of the University of Pécs and Semmelweis University identified a marker that is responsible for the success of artificial fertilisation and published the finding in the journal Nature Scientific Reports. Dr. Éva Pállinger, associate professor of …

Page 1 of 912345...Last »